TARDBP and Parkinson disease: Other biomarkers such as those associated with α-syn and TDP43 pathologies, though promising, need to be validated for diagnostic purposes in PD and FTD, respectively, before they can be reliably investigated to detect these diseases in case of psychiatric manifestations.